TGIF2

TGIF2 is a TALE-superclass homeodomain transcriptional repressor that controls cell fate decisions in development and disease by recruiting histone deacetylase complexes to target gene promoters and by modulating TGF-β/Nodal–Smad signaling. TGIF2 represses transcription through direct recruitment of HDAC1 and the mSin3/SIN3A corepressor complex, and unlike the related TGIF1, it does not interact with CtBP, functioning as a context-independent repressor of both TGF-β-dependent and -independent targets (PMID:11427533, PMID:16436215). EGFR/RAS/ERK-mediated phosphorylation stabilizes TGIF2 protein and is required for its ability to recruit HDAC1 to promoters such as E-cadherin, thereby driving EMT and cancer stemness, while TGIF2 also participates in multiprotein transcriptional complexes (e.g., JICD1–DDX17–SMAD3–TGIF2) that activate SOX2 expression (PMID:31871777, PMID:36647029, PMID:36417870). In vivo, Tgif2 functions redundantly with Tgif1 to limit Nodal signaling during gastrulation and axial patterning, and independently directs lineage decisions including pancreas-liver fate specification, photoreceptor differentiation, and neural stem cell maintenance (PMID:20040491, PMID:28193997, PMID:27639517).

1. 2000 Medium

   Establishing TGIF2 as a nuclear TALE-homeodomain protein resolved the basic subcellular context in which it operates.

   Evidence Epitope-tagged cDNA transfection with nuclear localization assay in mammalian cells

   PMID:11006116

   Open questions at the time

   • No DNA-binding specificity or target genes identified at this stage
   • Functional role beyond nuclear localization uncharacterized
2. 2001 High

   Demonstrating that TGIF2 recruits HDAC1 and interacts with TGF-β-activated Smads — but unlike TGIF1 cannot bind CtBP — established it as a context-independent transcriptional repressor that attenuates Smad signaling.

   Evidence Reciprocal co-immunoprecipitation, transcriptional reporter assays, and DNA-binding assays

   PMID:11427533

   Open questions at the time

   • Endogenous chromatin targets not identified
   • In vivo requirement not tested
3. 2006 Medium

   Identification of mSin3 as an additional corepressor partner and characterization of splice variants showed that TGIF2 represses both TGF-β-dependent and -independent transcription through multiple corepressor complexes.

   Evidence Co-immunoprecipitation and transcriptional reporter assays with full-length and short splice forms of mouse Tgif2

   PMID:16436215

   Open questions at the time

   • Relative contribution of HDAC1 vs. mSin3 recruitment not dissected
   • No in vivo confirmation of splice-variant-specific functions
4. 2010 High

   Genetic epistasis in compound-null mice proved that Tgif1 and Tgif2 redundantly limit Nodal signaling in vivo, as their combined loss caused gastrulation failure rescuable by reducing Nodal dosage.

   Evidence Compound null and conditional epiblast-deleted mouse mutants with Nodal dose-reduction rescue

   PMID:20040491

   Open questions at the time

   • Direct chromatin targets mediating Nodal repression not mapped
   • Individual contribution of TGIF2 vs. TGIF1 in this context remains unclear
5. 2016 Medium

   Extending the developmental scope, loss-of-function studies showed TGIF2 contributes redundantly with TGIF1 to axial patterning via Hox gene regulation, and independently regulates photoreceptor rod vs. cone fate in the retina.

   Evidence Single and compound null mouse mutants with Hoxc6 expression analysis; shRNA knockdown and conditional overexpression in retinal explants

   PMID:27187787 PMID:27639517

   Open questions at the time

   • Direct promoter binding at Hox loci not demonstrated
   • Mechanism linking TGIF2 to rod/cone specification unknown
6. 2017 High

   Three studies collectively broadened TGIF2's role: forced expression in hepatocytes induced a pancreatic progenitor-like program, loss of Tgif1/2 derepressed Evi5l to reduce primary cilia and Shh signaling, and TGIF2 was found to directly bind and repress the FCMR promoter to promote metastasis.

   Evidence AAV-mediated Tgif2 overexpression in mouse hepatocytes with transcriptome profiling; ChIP, siRNA rescue, and cilia quantification in MEFs; luciferase promoter assay and nude mouse metastasis model

   PMID:27956704 PMID:28193997 PMID:32572908

   Open questions at the time

   • Endogenous requirement for TGIF2 in pancreas specification not tested (gain-of-function only)
   • Whether TGIF2 directly binds Evi5l promoter (ChIP was for TGIF1)
7. 2018 Medium

   Showing that nuclear PKM2 targets TGIF2 for ubiquitin-proteasome-dependent degradation revealed a post-translational control mechanism governing TGIF2 protein levels.

   Evidence MG132 proteasome inhibition, PKM2 knockdown, mRNA/protein discordance analysis in oral squamous cell carcinoma

   PMID:30333907

   Open questions at the time

   • E3 ligase mediating TGIF2 ubiquitination not identified
   • Direct PKM2–TGIF2 physical interaction not shown
8. 2019 High

   EGFR/RAS/ERK-mediated phosphorylation was shown to stabilize TGIF2 protein and be required for OCT4 promoter binding and cancer stem cell properties, linking upstream signaling to TGIF2 transcriptional activity.

   Evidence Phosphorylation-deficient mutagenesis, ChIP, luciferase reporter assays, and xenograft mouse models

   PMID:31871777

   Open questions at the time

   • Specific phosphorylation sites and their individual contributions not fully mapped
   • Whether phosphorylation controls all TGIF2 targets or a subset is unknown
9. 2022 High

   Two studies expanded TGIF2's transcriptional partnerships: it was identified as a component of a JICD1–DDX17–SMAD3–TGIF2 complex that activates SOX2 to drive cancer stemness, and separately, LSD1-mediated epigenetic silencing of the TGIF2 promoter was linked to neuronal apoptosis in an autism model.

   Evidence Co-IP, ChIP-seq, and proteomics for the JICD1 complex; ChIP-qPCR and adenoviral overexpression with behavioral testing in mice

   PMID:35592894 PMID:36417870

   Open questions at the time

   • Whether TGIF2 acts as repressor or activator in the JICD1 complex is ambiguous
   • Causal role of TGIF2 downregulation in autism pathogenesis not established
10. 2023 High

    ERK-dependent phosphorylation was mechanistically linked to HDAC1 recruitment at the E-cadherin promoter, showing that phosphorylation controls the repressor–corepressor interaction driving EMT.

    Evidence Reciprocal Co-IP of TGIF2–HDAC1, ChIP on E-cadherin promoter, phosphorylation-deficient mutants, and xenograft models in lung adenocarcinoma

    PMID:36647029

    Open questions at the time

    • Structural basis of phosphorylation-dependent HDAC1 recruitment unknown
    • Genome-wide scope of phospho-TGIF2-dependent repression not determined
11. 2025 Medium

    Recent work identified a TGIF2–Smad2–SOX2–EGFR positive feedback loop in pancreatic cancer, TGIF2 transcriptional activation of HMGB3 in esophageal cancer, and TGIF2 interaction with SIN3A/HDAC to maintain neural stem cell identity, revealing context-dependent activator and repressor functions.

    Evidence ChIP, Co-IP, siRNA rescue, xenograft models; luciferase reporter and ChIP for HMGB3 promoter; RNA-seq, ATAC-seq, and in vivo NSC overexpression/knockdown (preprint for NSC study)

    PMID:39781447 PMID:41716633 PMID:bio_10.1101_2025.02.13.635953

    Open questions at the time

    • Neural stem cell study is a preprint awaiting peer review
    • How TGIF2 switches between transcriptional repression and activation is mechanistically unresolved
    • In vivo requirement for TGIF2 in adult neural stem cell niches not demonstrated

• Key unresolved questions include the structural basis of TGIF2's dual repressor/activator function, the identity of the E3 ubiquitin ligase controlling its turnover, and genome-wide maps of direct TGIF2 binding sites across developmental and disease contexts.
• No crystal or cryo-EM structure of TGIF2 or its complexes
• No genome-wide TGIF2 ChIP-seq in normal developmental tissues
• E3 ligase for TGIF2 ubiquitination unidentified